Crummy Coupons

prescription_2When low copay generic drugs face identical higher copay patent drugs, patients buy generics. If, however, the brand-name drug comes with a coupon reducing the copay below that of the generic drug copay, patent drug sales rise. Regrettably, the coupon doesn’t lower the amount paid by the insurer for the identical high-priced name-brand drug. Thus, coupons needlessly raise drug spending by billions/year and should be prohibited when generics exist.

Share This Post
Facebook Twitter Email


  1. Perhaps the issue is with the random increase in medication cost by pharmaceutical companies. The assumption that generic medications are equal to brand medication is false and has the potential to ultimately require greater medical intervention and monitoring, leading to an increase in medical care cost.

Speak Your Mind


This site uses Akismet to reduce spam. Learn how your comment data is processed.